infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Services
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 7 of 2,037 articles

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • New drugs take aim at hepatitis C, spur debate on whether to test baby boomers

    Canadian Press / 18 January 2011

  • Peregrine Initiates Randomized Phase II Trial of Bavituximab in Chronic Hepatitis C

    Market Wire / 10 January 2011

  • Treatment issues

    Bristol-Myers Squibb and Pharmasset Enter into a Clinical Collaboration Agreement for Proof of Concept Combination Study in Patients Chronically Infected with Hepatitis C

    Business Wire / 10 January 2011

  • Treatment issues

    Merck Beats Vertex to FDA Hep C Filing

    The Street / 07 January 2011

  • Liver disease a possible predictor of stroke: Study

    Eurekalert Medicine & Health / 07 January 2011

  • Treatment issues

    Pharmasset Reports Positive Results from its HCV Clinical Programs

    Pharmasset / 06 January 2011

  • Treatment issues

    Anadys Pharmaceuticals Initiates Phase IIb Study of ANA598 in HCV Patients

    PR Newswire / 05 January 2011

← Prev1...200201202203204Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2021. All rights reserved. We are not responsible for the content of external websites.

We are grateful to Abbvie, Janssen, Merck and Gilead for funding infohep.org. Our funders have had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

NAM working with the World Hepatitis Alliance and the European Liver Patients Association

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//   www.worldhepatitisalliance.org   www.elpa-info.org